Tonight, Reuters has an exclusive story, straight from Whitehouse Station, setting a pretty short path to the return of Zilmax. Here’s more of my reporting the back story (on why it was initially pulled) — and a bit from Reuters‘ story, tonight — do go read it all:
. . . .The email from company spokeswoman Pamela Eisele said Merck was “committed to completing this as quickly as possible, while also ensuring it is conducted appropriately and with rigorous scientific measures.”
In a separate statement, Merck said it has formed an advisory board that includes representatives from meat processors, cattle feeder operations, producers, veterinarians, academics and industry consultants. . . .
We will keep you posted.